Results 111 to 120 of about 5,403 (175)

Radiation-Induced Loss of Tumor-Reactive T Cells Calls for More Rationally Designed Radioimmunotherapy Approaches. [PDF]

Int J Radiat Oncol Biol Phys
Said I, Awan MJ, Wong SJ, Memon AA, Kearl T, Hematti P, Massey B, Bruening J, Akakpo K, Zenga J, Himburg HA.   +10 more
europepmc   +1 more source

Construction and Evaluation of Guanylyl Cyclase C-Specific Antibody for Noninvasive Diagnosis and Targeted Therapy of Colorectal Cancer. [PDF]

J Nucl Med
Rong Z, Liu H, Teng X, Chen L, Gu Y, Dong B, Duan X, Wang X, Pang X.   +8 more
europepmc   +1 more source

Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in Patients with High-risk B-cell Lymphomas. [PDF]

Mol Cancer Ther
Orozco JJ, Matesan MC, Lundberg SJ, Haaf RL, Miyaoka RS, Fisher DR, Gooley TA, Green DJ, Sandmaier BM, Martin PS, Gopal AK.   +10 more
europepmc   +1 more source

¹⁶¹Tb Radioimmunotherapy as a Treatment for CD30-Positive Lymphomas. [PDF]

J Nucl Med
Rioja-Blanco E, Banz Y, Schlapbach C, Novak U, Chiorazzo T, Bertschi NL, Bernhardt P, Grundler PV, van der Meulen NP, Grzmil M, Schibli R, Behe M.   +11 more
europepmc   +1 more source

From mitochondrial dysregulation to ferroptosis: Exploring new strategies and challenges in radioimmunotherapy (Review). [PDF]

Int J Oncol
Wang T, Zhou X, Yin X, Zhang A, Fan Y, Chen K, Tao H, Tang Z, Zhang P, He X, Yin L.   +10 more
europepmc   +1 more source

Impacts of combining PD-L1 inhibitor and radiotherapy on the tumour immune microenvironment in a mouse model of esophageal squamous cell carcinoma. [PDF]

BMC Cancer
Yin Z, Zhang H, Zhang K, Yue J, Tang R, Wang Y, Deng Q, Yu Q.   +7 more
europepmc   +1 more source

Differentiated T Lymphocytes and Cancer Cell Mitochondrial Metabolism to Enhance Radioimmunotherapy by a Biomimetic Nanozyme System. [PDF]

Adv Sci (Weinh)
Zhang H, Deng Y, Lu Y, Wang M, Qiao K, Yang Z, Ning S, Liu T.   +7 more
europepmc   +1 more source

Emerging frontiers in diffuse intrinsic pontine glioma treatment: A new hope. [PDF]

Neuro Oncol
Christian EA, Rutka JT.
europepmc   +1 more source

An immunostimulant nanomedicine enhances radioimmunotherapy by remodeling the tumor immunosuppressive landscape after radiotherapy. [PDF]

Acta Pharm Sin B
Jiang M, Chen M, Zou W, Xie Y, Shi J, Liu J, Chen A, Zhao X.   +7 more
europepmc   +1 more source

Radiotherapy combined with immunotherapy for esophageal cancer: current status and challenge. [PDF]

J Cancer Res Clin Oncol
Wang Y, Gu J, Sun X.
europepmc   +1 more source